Sign In
Buy GKOS
$113.64
+2.86 (+2.58%)
At Close: Jun 03, 2026
LS Investment Advisors LLC Takes $39,000 Position in Glaukos Corp (NYSE:GKOS)
10:30am, Monday, 27'th Apr 2020
LS Investment Advisors LLC acquired a new stake in Glaukos Corp (NYSE:GKOS) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm
Glaukos Corporation to Release First Quarter 2020 Financial Results after Market Close on May 7
12:30pm, Tuesday, 21'st Apr 2020
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to
Glaukos: Assessing The Value Proposition After Multiple Recent Deals
01:34am, Tuesday, 21'st Apr 2020
Glaukos completed 4 separate licensing and acquisition deals in 2019 that have expanded the company’s scope far beyond just the glaucoma market. The company con
Louisiana State Employees Retirement System Buys Shares of 10,720 Glaukos Corp (NYSE:GKOS)
10:20am, Monday, 20'th Apr 2020
Louisiana State Employees Retirement System bought a new stake in Glaukos Corp (NYSE:GKOS) during the first quarter, according to the company in its most recent disclosure with the Securities and Exch
Nuveen Asset Management LLC Acquires 15,009 Shares of Glaukos Corp (NYSE:GKOS)
09:08am, Saturday, 18'th Apr 2020
Nuveen Asset Management LLC boosted its position in Glaukos Corp (NYSE:GKOS) by 8.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 192,543 s
Glaukos Corp (NYSE:GKOS) Shares Purchased by Exchange Traded Concepts LLC
09:34am, Thursday, 16'th Apr 2020
Exchange Traded Concepts LLC boosted its position in shares of Glaukos Corp (NYSE:GKOS) by 156.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The
Head to Head Contrast: Glaukos (NYSE:GKOS) & FRESENIUS SE &/S (NYSE:FSNUY)
05:56am, Thursday, 16'th Apr 2020
FRESENIUS SE &/S (OTCMKTS:FSNUY) and Glaukos (NYSE:GKOS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommen
Analysis of COVID-19-Global Glaucoma Surgery Devices Market 2020-2024 | Evolving Opportunities with Alcon Inc. and Allergan Plc | Technavio
10:00pm, Wednesday, 15'th Apr 2020
The glaucoma surgery devices market size has the potential to grow by USD 1.53 billion during 2020-2024
U.S. STOCKS ON THE MOVE-Banks, Aphria, Tesla, UnitedHealth, J.C. Penney
01:27pm, Wednesday, 15'th Apr 2020
* Eikon search string for individual stock moves:* The Day Ahead newsletter: The Morning News Call newsletter: Wall Street’s main indexes were set to slide at the open on Wednesday, as a reco…
Alliancebernstein L.P. Trims Stake in Glaukos Corp (NYSE:GKOS)
08:48am, Tuesday, 14'th Apr 2020
Alliancebernstein L.P. reduced its position in shares of Glaukos Corp (NYSE:GKOS) by 3.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SE
652,313 Shares in Glaukos Corp (NYSE:GKOS) Bought by Norges Bank
10:04am, Monday, 13'th Apr 2020
Norges Bank bought a new position in shares of Glaukos Corp (NYSE:GKOS) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 652,31
Glaucoma Surgery Devices Market Size Worth $2.6 Billion by 2027: Grand View Research, Inc.
08:35am, Monday, 13'th Apr 2020
The global glaucoma surgery devices market size is estimated to reach USD 2.6 billion by 2027, registering a CAGR of 6.9%, according to a new report by Grand View Research, Inc. Growing geriatric popu
Contrasting Shockwave Medical (NASDAQ:SWAV) & Glaukos (NASDAQ:GKOS)
05:32am, Sunday, 12'th Apr 2020
Shockwave Medical (NASDAQ:SWAV) and Glaukos (NYSE:GKOS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valu
Glaukos (NYSE:GKOS) Earns "Buy" Rating from Piper Sandler
07:06am, Friday, 10'th Apr 2020
Glaukos (NYSE:GKOS)‘s stock had its “buy” rating reaffirmed by stock analysts at Piper Sandler in a research report issued to clients and investors on Thursday, TipRanks reports. GKOS has been t
BRIEF-Glaukos Sees Q1 2020 Sales $55 Million To $55.3 Million
01:20pm, Thursday, 09'th Apr 2020
Glaukos Corp:
